Protective effect of the omega-3 polyunsaturated fatty acids: Eicosapentaenoic acid/Docosahexaenoic acid 1:1 ratio on cardiovascular disease risk markers in rats

被引：0
|
作者：
Laura Lluís
Núria Taltavull
Mònica Muñoz-Cortés
Vanesa Sánchez-Martos
Marta Romeu
Montse Giralt
Eunice Molinar-Toribio
Josep Lluís Torres
Jara Pérez-Jiménez
Manuel Pazos
Lucía Méndez
José M Gallardo
Isabel Medina
M Rosa Nogués
机构：
[1] Faculty of Medicine and Health Sciences,Unit of Pharmacology
[2] Rovira i Virgili University,undefined
[3] Institute of Advanced Chemistry of Catalonia –CSIC (IQAC-CSIC),undefined
[4] Institute of Marine Research-CSIC (IIM-CSIC),undefined
来源：
Lipids in Health and Disease | / 12卷
关键词：
Omega-3 polyunsaturated fatty acids (PUFA); Eicosapentaenoic acid (EPA); Docosahexaenoic acid (DHA); Fish oils; Oxidative stress; Antioxidant status; Cardiovascular disease risk; Insulin resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] The role of omega-3 polyunsaturated fatty acids eicosapentaenoic and docosahexaenoic acids in the treatment of major depression and Alzheimer's disease: Acting separately or synergistically?
    Song, Cai
    Shieh, Chu-Hsin
    Wu, Yi-Shyuan
    Kalueff, Allan
    Gailcvvad, Siddharth
    Su, Kuan-Pin
    PROGRESS IN LIPID RESEARCH, 2016, 62 : 41 - 54
  • [32] Bioavailability and metabolism of omega-3 polyunsaturated fatty acids in pigs and omega-3 polyunsaturated fatty acid-enriched pork: A review
    Huang, C.
    Chiba, L., I
    Bergen, W. G.
    LIVESTOCK SCIENCE, 2021, 243
  • [33] The omega-6/omega-3 fatty acid ratio, genetic variation, and cardiovascular disease
    Simopoulos, Artemis P.
    ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION, 2008, 17 : 131 - 134
  • [34] Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review
    Oscarsson, Jan
    Hurt-Camejo, Eva
    LIPIDS IN HEALTH AND DISEASE, 2017, 16
  • [35] Cardiovascular protective effects of n-3 polyunsaturated fatty acids with special emphasis on docosahexaenoic acid
    Hirafuji, M
    Machida, T
    Hamaue, N
    Minami, M
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 92 (04) : 308 - 316
  • [36] Omega-3 polyunsaturated fatty acid biomarkers and risk of type 2 diabetes, cardiovascular disease, cancer, and mortality
    Jiang, Hong
    Wang, Lina
    Wang, Duolao
    Yan, Ni
    Li, Chao
    Wu, Min
    Wang, Fan
    Mi, Baibing
    Chen, Fangyao
    Jia, Wanru
    Liu, Xi
    Lv, Jiaxin
    Liu, Yan
    Lin, Jing
    Ma, Le
    CLINICAL NUTRITION, 2022, 41 (08) : 1798 - 1807
  • [37] Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review
    Jan Oscarsson
    Eva Hurt-Camejo
    Lipids in Health and Disease, 16
  • [38] Target patients for polyunsaturated omega-3 fatty acids in cardiovascular disease prevention
    Kopec, Grzegorz
    Podolec, Piotr
    KARDIOLOGIA POLSKA, 2009, 67 (11) : 1299 - 1303
  • [39] Docosahexaenoic Acid (DHA) and Long Chain Omega-3 Fatty Acids: Clinical Relevance for the Cardiovascular System
    Saller, Reinhard
    Roemer-Luethi, Christine
    Mueller, Monika
    Brignoli, Reto
    Noll, Georg
    Meier, Remy
    SCHWEIZERISCHE ZEITSCHRIFT FUER GANZHEITSMEDIZIN, 2006, 18 (05): : 272 - 280
  • [40] Indications for Omega-3 Long Chain Polyunsaturated Fatty Acid in the Prevention and Treatment of Cardiovascular Disease
    Nestel, Paul
    Clifton, Peter
    Colquhoun, David
    Noakes, Manny
    Mori, Trevor A.
    Sullivan, David
    Thomas, Beth
    HEART LUNG AND CIRCULATION, 2015, 24 (08): : 769 - 779
12345